NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

腎臟癌症治療藥的全球市場(2021年):COVID-19影響與到2030年前的復甦

Kidney Cancer Drugs Global Market Report 2021: COVID-19 Impact And Recovery To 2030

出版商 The Business Research Company 商品編碼 1014881
出版日期 按訂單生產 內容資訊 英文 175 Pages
商品交期: 2-10個工作天內
價格
腎臟癌症治療藥的全球市場(2021年):COVID-19影響與到2030年前的復甦 Kidney Cancer Drugs Global Market Report 2021: COVID-19 Impact And Recovery To 2030
出版日期: 按訂單生產內容資訊: 英文 175 Pages
簡介

本報告提供全球腎臟癌症治療藥市場的相關調查,提供市場規模和預測,成長及阻礙因素,COVID-19的影響,競爭情形,市場佔有率,市場趨勢與策略,類型·產品·終端用戶·各區各國的市場分析,主要企業的簡介等資訊。

目錄

第1章 摘要整理

第2章 腎臟癌症治療藥市場特徵

第3章 腎臟癌症治療藥的市場趨勢與策略

第4章 COVID-19對腎臟癌症治療藥的影響

第5章 腎臟癌症治療藥的市場規模與成長

  • 全球腎臟癌症治療藥的市場實際成果(2015-2020)
    • 市場成長要素
    • 市場阻礙因素
  • 全球腎臟癌症治療藥市場預測(2020-2025F,2030F)
    • 市場成長要素
    • 市場阻礙因素

第6章 腎臟癌症治療藥市場區隔

  • 全球腎臟癌症治療藥市場,各類型市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)
  • 腎細胞癌症(RCC)
  • 轉移表皮癌症(TCC)或尿路表皮癌症(UCC)
  • 全球腎臟癌症治療藥市場,各產品市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)
  • Nexavar
  • SUTENT
  • Afinitor
  • Votrient(Pazopanib)
  • Avastin(Bevacizumab)
  • inrita(Axitinib )
  • Temsirolimus(Torisel)
  • Proleukin(Aldesleukin)
  • 其他
  • 全球腎臟癌症治療藥市場,各終端用戶市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)
  • 醫院
  • 診所
  • 研究中心
  • 其他

第7章 腎臟癌症治療藥市場地區及國分析

  • 全球腎臟癌症治療藥市場,各地區,實際成果及預測(2015-2020,2020-2025F,2030F)
  • 全球腎臟癌症治療藥市場,各國,實際成果及預測(2015-2020,2020-2025F,2030F)

第8章 亞太地區的腎臟癌症治療藥市場

  • 亞太地區的腎臟癌症治療藥市場概要
  • 地區資訊,COVID-19的影響,市場資訊,背景資訊,政府的積極推動,法規,法規機關,主要的協會,免稅,公司稅結構,投資,主要企業
  • 亞太地區的腎臟癌症治療藥市場,各類型市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)
  • 亞太地區的腎臟癌症治療藥市場,各產品市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)
  • 亞太地區的腎臟癌症治療藥市場,各終端用戶市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)

第9章 中國的腎臟癌症治療藥市場

  • 中國的腎臟癌症治療藥市場概要
  • 中國的腎臟癌症治療藥市場,各類型市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)
  • 中國的腎臟癌症治療藥市場,各產品市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)
  • 中國的腎臟癌症治療藥市場,各終端用戶市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)

第10章 印度的腎臟癌症治療藥市場

  • 印度的腎臟癌症治療藥市場,各類型市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)
  • 印度的腎臟癌症治療藥市場,各產品市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)
  • 印度的腎臟癌症治療藥市場,各終端用戶市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)

第11章 日本的腎臟癌症治療藥市場

  • 日本的腎臟癌症治療藥市場,各類型市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)
  • 日本的腎臟癌症治療藥市場,各產品市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)
  • 日本的腎臟癌症治療藥市場,各終端用戶市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)

第12章 澳洲的腎臟癌症治療藥市場

  • 澳洲的腎臟癌症治療藥市場,各類型市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)
  • 澳洲的腎臟癌症治療藥市場,各產品市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)
  • 澳洲的腎臟癌症治療藥市場,各終端用戶市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)

第13章 印尼的腎臟癌症治療藥市場

  • 印尼的腎臟癌症治療藥市場,各類型市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)
  • 印尼的腎臟癌症治療藥市場,各產品市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)
  • 印尼的腎臟癌症治療藥市場,各終端用戶市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)

第14章 韓國的腎臟癌症治療藥市場

  • 韓國的腎臟癌症治療藥市場,各類型市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)
  • 韓國的腎臟癌症治療藥市場,各產品市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)
  • 韓國的腎臟癌症治療藥市場,各終端用戶市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)

第15章 西歐的腎臟癌症治療藥市場

  • 西歐的腎臟癌症治療藥市場概要
  • 西歐的腎臟癌症治療藥市場,各類型市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)
  • 西歐的腎臟癌症治療藥市場,各產品市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)
  • 西歐的腎臟癌症治療藥市場,各終端用戶市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)

第16章 英國的腎臟癌症治療藥市場

  • 英國的腎臟癌症治療藥市場,各類型市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)
  • 英國的腎臟癌症治療藥市場,各產品市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)
  • 英國的腎臟癌症治療藥市場,各終端用戶市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)

第17章 德國的腎臟癌症治療藥市場

  • 德國的腎臟癌症治療藥市場,各類型市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)
  • 德國的腎臟癌症治療藥市場,各產品市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)
  • 德國的腎臟癌症治療藥市場,各終端用戶市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)

第18章 法國的腎臟癌症治療藥市場

  • 法國的腎臟癌症治療藥市場,各類型市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)
  • 法國的腎臟癌症治療藥市場,各產品市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)
  • 法國的腎臟癌症治療藥市場,各終端用戶市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)

第19章 東歐的腎臟癌症治療藥市場

  • 東歐的腎臟癌症治療藥市場概要
  • 東歐的腎臟癌症治療藥市場,各類型市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)
  • 東歐的腎臟癌症治療藥市場,各產品市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)
  • 東歐的腎臟癌症治療藥市場,各終端用戶市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)

第20章 俄羅斯的腎臟癌症治療藥市場

  • 俄羅斯的腎臟癌症治療藥市場,各類型市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)
  • 俄羅斯的腎臟癌症治療藥市場,各產品市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)
  • 俄羅斯的腎臟癌症治療藥市場,各終端用戶市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)

第21章 北美的腎臟癌症治療藥市場

  • 北美的腎臟癌症治療藥市場概要
  • 北美的腎臟癌症治療藥市場,各類型市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)
  • 北美的腎臟癌症治療藥市場,各產品市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)
  • 北美的腎臟癌症治療藥市場,各終端用戶市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)

第22章 美國的腎臟癌症治療藥市場

  • 美國的腎臟癌症治療藥市場概要
  • 美國的腎臟癌症治療藥市場,各類型市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)
  • 美國的腎臟癌症治療藥市場,各產品市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)
  • 美國的腎臟癌症治療藥市場,各終端用戶市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)

第23章 南美的腎臟癌症治療藥市場

  • 南美的腎臟癌症治療藥市場概要
  • 南美的腎臟癌症治療藥市場,各類型市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)
  • 南美的腎臟癌症治療藥市場,各產品市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)
  • 南美的腎臟癌症治療藥市場,各終端用戶市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)

第24章 巴西的腎臟癌症治療藥市場

  • 巴西的腎臟癌症治療藥市場,各類型市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)
  • 巴西的腎臟癌症治療藥市場,各產品市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)
  • 巴西的腎臟癌症治療藥市場,各終端用戶市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)

第25章 中東的腎臟癌症治療藥市場

  • 中東的腎臟癌症治療藥市場概要
  • 中東的腎臟癌症治療藥市場,各類型市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)
  • 中東的腎臟癌症治療藥市場,各產品市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)
  • 中東的腎臟癌症治療藥市場,各終端用戶市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)

第26章 非洲的腎臟癌症治療藥市場

  • 非洲的腎臟癌症治療藥市場概要
  • 非洲的腎臟癌症治療藥市場,各類型市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)
  • 非洲的腎臟癌症治療藥市場,各產品市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)
  • 非洲的腎臟癌症治療藥市場,各終端用戶市場區隔,實際成果及預測(2015-2020,2020-2025F,2030F)

第27章 腎臟癌症治療藥市場競爭情形和企業簡介

  • 腎臟癌症治療藥市場競爭情形
  • 腎臟癌症治療藥市場企業簡介
    • Bayer AG
    • Pfizer Inc
    • Novartis International AG
    • Exelixis, Inc
    • F. Hoffmann-La Roche Ag

第28章 腎臟癌症治療藥的開發平台分析

第29章 腎臟癌症治療藥市場上主要合併和收購

第30章 腎臟癌症治療藥市場未來展望和潛在的分析

第31章 附錄

目錄

Kidney Cancer Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global kidney cancer drugs market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the kidney cancer drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Kidney Cancer Drugs Market Global Report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The Market Characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered: 1) By Type: Renal Cell Carcinoma (RCC); Transitional Cell Carcinoma (TCC) or Urothelial cell carcinoma (UCC)

2) By Product: Nexavar (Sorafenib); Sutent (Sunitinib); Afinitor (Everolimus); Votrient (Pazopanib); Avastin (Bevacizumab); Inlyta (Axitinib); Torisel (Temsirolimus); Proleukin (Aldesleukin); Others

3) By End Users: Hospitals; Clinics; Research Center; Others

Companies Mentioned: Bayer AG; Pfizer Inc; Novartis International AG; Exelixis; F. Hoffmann-La Roche Ag

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Kidney Cancer Drugs Market Characteristics

3. Kidney Cancer Drugs Market Trends And Strategies

4. Impact Of COVID-19 On Kidney Cancer Drugs

5. Kidney Cancer Drugs Market Size And Growth

  • 5.1. Global Kidney Cancer Drugs Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Kidney Cancer Drugs Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Kidney Cancer Drugs Market Segmentation

  • 6.1. Global Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Renal Cell Carcinoma (RCC)
  • Transitional Cell Carcinoma (TCC) or Urothelial cell carcinoma (UCC)
  • 6.2. Global Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Nexavar (Sorafenib)
  • Sutent (Sunitinib)
  • Afinitor (Everolimus)
  • Votrient (Pazopanib)
  • Avastin (Bevacizumab)
  • Inlyta (Axitinib)
  • Torisel (Temsirolimus)
  • Proleukin (Aldesleukin)
  • Others
  • 6.3. Global Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospitals
  • Clinics
  • Research Center
  • Others

7. Kidney Cancer Drugs Market Regional And Country Analysis

  • 7.1. Global Kidney Cancer Drugs Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Kidney Cancer Drugs Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Kidney Cancer Drugs Market

  • 8.1. Asia-Pacific Kidney Cancer Drugs Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.4. Asia-Pacific Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Kidney Cancer Drugs Market

  • 9.1. China Kidney Cancer Drugs Market Overview
  • 9.2. China Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.4. China Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Kidney Cancer Drugs Market

  • 10.1. India Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.3. India Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Kidney Cancer Drugs Market

  • 11.1. Japan Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.3. Japan Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Kidney Cancer Drugs Market

  • 12.1. Australia Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.3. Australia Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Kidney Cancer Drugs Market

  • 13.1. Indonesia Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.3. Indonesia Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Kidney Cancer Drugs Market

  • 14.1. South Korea Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.3. South Korea Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Kidney Cancer Drugs Market

  • 15.1. Western Europe Kidney Cancer Drugs Market Overview
  • 15.2. Western Europe Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.4. Western Europe Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Kidney Cancer Drugs Market

  • 16.1. UK Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.3. UK Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Kidney Cancer Drugs Market

  • 17.1. Germany Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.3. Germany Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Kidney Cancer Drugs Market

  • 18.5. France Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.6. France Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.7. France Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Kidney Cancer Drugs Market

  • 19.1. Eastern Europe Kidney Cancer Drugs Market Overview
  • 19.2. Eastern Europe Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.4. Eastern Europe Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Kidney Cancer Drugs Market

  • 20.1. Russia Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.3. Russia Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Kidney Cancer Drugs Market

  • 21.1. North America Kidney Cancer Drugs Market Overview
  • 21.2. North America Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.4. North America Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Kidney Cancer Drugs Market

  • 22.1. USA Kidney Cancer Drugs Market Overview
  • 22.2. USA Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.4. USA Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Kidney Cancer Drugs Market

  • 23.1. South America Kidney Cancer Drugs Market Overview
  • 23.2. South America Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.4. South America Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Kidney Cancer Drugs Market

  • 24.1. Brazil Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.3. Brazil Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Kidney Cancer Drugs Market

  • 25.1. Middle East Kidney Cancer Drugs Market Overview
  • 25.2. Middle East Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.4. Middle East Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Kidney Cancer Drugs Market

  • 26.1. Africa Kidney Cancer Drugs Market Overview
  • 26.2. Africa Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.4. Africa Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Kidney Cancer Drugs Market Competitive Landscape And Company Profiles

  • 27.1. Kidney Cancer Drugs Market Competitive Landscape
  • 27.2. Kidney Cancer Drugs Market Company Profiles
    • 27.2.1. Bayer AG
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Pfizer Inc
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Novartis International AG
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Exelixis, Inc
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. F. Hoffmann-La Roche Ag
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Kidney Cancer Drugs Pipeline Analysis

29. Key Mergers And Acquisitions In The Kidney Cancer Drugs Market

30. Kidney Cancer Drugs Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer